August 29, 2014 – Novartis has a strong history of CR activities, and transparent reporting is a central part of our commitment to corporate responsibility. We have publicly reported on our performance in this area since 2000 through our Annual Report and several online and printed materials.

For 2013, we have consolidated information previously published in our separate GRI; Health, Safety and Environment; and United Nations Global Compact reports into a single Corporate Responsibility Performance Report.

This report enhances our transparency in several key …

August 29, 2014 – Life-saving medicines from Sandoz have arrived at the University Teaching Hospital in Lusaka, Zambia. The donated units of benzathine penicillin will support a new rheumatic heart disease study by the Novartis Institutes for BioMedical Research (NIBR). Penicillin prophylaxis is the only way by which new cases of rheumatic heart disease can be prevented.
Read more.